Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: Clinical findings and classification according to pathogenesis;Alterazioni della captazione e della distribuzione epatica dei mezzi di contrasto superparamagnetici organo-specifici per Risonanza Magnetica. Rilievo clinico e classificazione sulla base del meccanismo patogenetico

Radiologia Medica

Volumn 108, Issue 1-2, 2004, Pages 92-106

  Macarini, Luca ^a   Marini, Stefania ^a   Murrone, Mario ^a   Ettorre, Giovanni Carlo ^b  

^a POLICLINICO   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Liver; Liver disease; Magnetic Resonance; Superparamagnetic contrast medium; Uptake and distribution alterations

Indexed keywords

CONTRAST MEDIUM; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG UPTAKE; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; KUPFFER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER METASTASIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; THROMBOSIS;

ADULT; AGED; ARTERIOVENOUS FISTULA; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FATTY LIVER; FEMALE; FERROSOFERRIC OXIDE; HEPATIC VEIN THROMBOSIS; HEPATITIS; HUMANS; IMAGE ENHANCEMENT; IRON; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PORTAL VEIN; RETROSPECTIVE STUDIES; SUSPENSIONS; VENOUS THROMBOSIS;

EID: 3843147155     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Giovagnoni A, Paci E, Valeri G et al: MRI in characterization of focal liver lesions: comparison of T2 weighting by conventional spin-echo and turbo spin-echo sequences. J Magn Reson Imaging 6: 589-595, 1996.
2. Di Cesare E, Cariello G, Barile A et al: Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media. Radiol Med 100: 245-250, 2000.
3. Matsuo M, Kanematsu M, Itoh K et al: Detection of malignant hepatic tumors: comparison of gadolinium- and ferumoxide-enhanced MR imaging. AJR 177: 637-643, 2001.
4. Vogl TJ, Hammerstingl R, Schwarz W et al: Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198: 881-887, 1996.
5. Paley MR, Mergo PJ, Torres GM et al: Characterization of focal hepatic lesions with ferumoxide-enhanced T2-weighted MR imaging. AJR 175: 159-163, 2000.
6. Reimer P, Rummeny EJ, Daldrup HE et al: Clinical results with Resovist: a phase 2 clinical trial. Radiology 195: 489-496, 1995.
7. Ros PR, Freeny PC, Harms SE et al: Hepatic MR imaging with ferumoxides: a multicenter clinical trial of safety and efficacy in the detection of focal hepatic lesions. Radiology 196: 481-488, 1995.
8. Seneterre E, Taourel P, Bouvier Y et al: Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200: 785-792, 1996.
9. Ferrucci JT, Stark DD: Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR 155: 943-950, 1990.
10. Stark DD, Weissleder R, Elizondo G et al: Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168: 297-301, 1988.
11. Arbab AS, Ichikawa T, Araki T et al: Detection of hepatocellular carcinoma and its metastases with various pulse sequences using superparamagnetic iron oxide (SHU-555-A). Abdom Imaging 25: 151-158, 2000.
12. Clement O, Frija G, Chambon C et al: Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging. Radiology 180: 31-36, 1991.
13. Elizondo G, Weissleder R, Stark DD: Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 174: 797-801, 1990.
14. Hundt W, Petsch R, Helmberger T et al: Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis. Eur Radiol 10: 409-416, 2000.
15. Lim JH, Choi D, Cho SK et al: Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220: 669-676, 2001.
16. Lwakatare F, Yamashita Y, Nakayama M et al: SPIO-enhanced MR imaging of focal fatty liver lesions. Abdom Imaging 26: 157-160, 2001.
17. Matsuo M, Kanematsu M, Kondo H et al: Confluent hepatic fibrosis in cirrhosis: ferumoxides-enhanced MR imaging findings. Abdom Imaging 26: 146-148, 2001.
18. Mori H, Yoshioka H, Ahmadi T et al: Early radiation effects on the liver demonstrated on superparamagnetic iron oxide-enhanced T1-weighted MRI. J Comput Assist Tomogr 24: 648-651, 2000.
19. Mori K, Yoshioka H, Itai Y et al: Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR 175: 1659-1664, 2000.
20. Scharf K, Hoffmann V, Lehnert T et al: Pseudolesions at T1-weighted gradient-echo imaging after administration of superparamagnetic iron oxide: comparison with portal perfusion abnormalities at CT during arterial portography. Radiology 207: 67-72, 1998.
21. Yamamoto H, Yamashita Y, Yoshimatsu S et al: Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 195: 106-112, 1995.
22. Dao T, Mathieu D, Nguyen-tan T et al: Value of MR imaging in evaluating focal fatty infiltration of the liver: preliminary study. Radiographics 11: 1003-1012, 1991.
23. Roth B, Fklelund M, Fan BG et al: Lipid deposition in Kupffer cells after parenteral fat nutrition in rats: biochemical and ultrastructural study. Intensive Care Med 22: 1224-1231, 1996.
24. Macarini L, Ettorre GC, Midiri M et al: Dual contrast MR imaging of the liver: consequential-combined use of positive and negative contrast agents in focal hepatic pathology (abs). Eur Radiol 10 (suppl. 1): 324-325, 2000.
25. Colagrande S, Carmignani L, Pagliari A et al: Le alterazioni transitorie della densità epatica non associate a lesioni focali. Radiol Med 104: 25-43, 2002.
26. Colagrande S, Centi N, Carmignani L et al: Significato ed etiopatogenesi dei fenomeni arteriali epatici (THAD) settoriali. Radiol Med 105: 180-187, 2003.
27. Ohtomo K, Baron RL, Dodd GD 3rd et al: Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 189: 871-874, 1993.
28. Earls JP, Theise N, Weinreb JC et al: Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201: 207-214, 1996.
29. Matsui O, Kadoya M, Kameyama T et al: Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 178: 493-497, 1991.